Clinafloxacin (also known as CI-960, PD127391, AM-1091) is a broad-spectrum fluoroquinolone class of antibiotic that inhibits both DNA gyrase and topoisomerase IV dually in Streptococcus pneumonia. It is a broad-spectrum antibiotic of the quinolone carboxylic acid class currently in development for intravenous and oral therapy of serious infections. Clinafloxacin is a novel fluoroquinolone antibiotic with potent broad-spectrum in vitro activity against gram-positive, gram-negative, and anaerobic pathogens.

纯度：≥98%

CAS：105956-99-8